메뉴 건너뛰기




Volumn 14, Issue 3, 2006, Pages 230-235

Comparison of the solubility and dissolution rate of gliclazide-β-cyclodextrin inclusion complexes prepared by liquid/ liquid extraction and neutralization

Author keywords

Cyclodextrin; Gliclazide; Liquid liquid extraction; Neutralization; Solubility

Indexed keywords

BETA CYCLODEXTRIN; GLICLAZIDE;

EID: 33751374141     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (19)
  • 1
    • 0022592084 scopus 로고
    • Hydroxypropyl-β-cyclodextrin: Preparation and characterization; effects on solubility of drugs
    • Pitha, J., Milecki, J., Fales, H., Pannell, L., Uekama, K. 1986. Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs. Int. J. Pharm. 29: 73-82.
    • (1986) Int. J. Pharm. , vol.29 , pp. 73-82
    • Pitha, J.1    Milecki, J.2    Fales, H.3    Pannell, L.4    Uekama, K.5
  • 2
    • 0025892402 scopus 로고
    • Influence of method of preparation on inclusion complexes of naproxen with different cyclodextrins
    • Blanco, J., Vila-Jato, J.L., Otero, F., Anguiano, S. 1991. Influence of method of preparation on inclusion complexes of naproxen with different cyclodextrins. Drug Dev. Ind. Pharm. 17: 943-945.
    • (1991) Drug Dev. Ind. Pharm. , vol.17 , pp. 943-945
    • Blanco, J.1    Vila-Jato, J.L.2    Otero, F.3    Anguiano, S.4
  • 4
    • 0021354954 scopus 로고
    • Inclusion complexation of metronidazole benzoate with β-cyclodextrin and its depression of anhydrate-hydrate transition in aqueous suspensions
    • Andersen, F.A., Bundgaard, H. 1984. Inclusion complexation of metronidazole benzoate with β-cyclodextrin and its depression of anhydrate-hydrate transition in aqueous suspensions. Int. J. Pharm. 19: 189-197.
    • (1984) Int. J. Pharm. , vol.19 , pp. 189-197
    • Andersen, F.A.1    Bundgaard, H.2
  • 5
    • 0022636544 scopus 로고
    • Characterization, dissolution and bioavailability in rats of ibuprofen-b-cyclodextrin complex system
    • Chow, D., Karara, A. 1986. Characterization, dissolution and bioavailability in rats of ibuprofen-b-cyclodextrin complex system. Int. J. Pharm. 28: 95-101.
    • (1986) Int. J. Pharm. , vol.28 , pp. 95-101
    • Chow, D.1    Karara, A.2
  • 7
    • 84985609923 scopus 로고
    • Cyclodextrin inclusion compounds in research and laboratory
    • Saenger, W. 1980. Cyclodextrin inclusion compounds in research and laboratory. Angew. Chem. Int. Ed. Engl. 19: 344-362.
    • (1980) Angew. Chem. Int. Ed. Engl. , vol.19 , pp. 344-362
    • Saenger, W.1
  • 8
    • 0346461917 scopus 로고    scopus 로고
    • Introduction and general overview of cyclodextrin chemistry
    • Szejtli, J. 1998. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98: 1743-1753.
    • (1998) Chem. Rev. , vol.98 , pp. 1743-1753
    • Szejtli, J.1
  • 9
    • 0029819323 scopus 로고    scopus 로고
    • Pharmaceutical applications of cyclodextrins. I. Drug solubilisation and stabilization
    • Loftsson, T., Brewster, M.E. 1996. Pharmaceutical applications of cyclodextrins. I. Drug solubilisation and stabilization. J. Pharm. Sci. 85: 1012-1025.
    • (1996) J. Pharm. Sci. , vol.85 , pp. 1012-1025
    • Loftsson, T.1    Brewster, M.E.2
  • 12
    • 0006721654 scopus 로고    scopus 로고
    • Solid-state characterization and dissolution characteristics of gliclazide-β-cyclodextrin inclusion complexes
    • Moyano, J.R., Arias-Blanco, M.J., Gines, J.M. Giordano, F. 1997. Solid-state characterization and dissolution characteristics of gliclazide-β-cyclodextrin inclusion complexes. Int. J. Pharm. 148: 211-217.
    • (1997) Int. J. Pharm. , vol.148 , pp. 211-217
    • Moyano, J.R.1    Arias-Blanco, M.J.2    Gines, J.M.3    Giordano, F.4
  • 13
    • 0033996850 scopus 로고    scopus 로고
    • Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin
    • Özkan, Y., Atay, T., Dikmen, N., Işimer, A., Aboul-Enein, HY. 2000. Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with beta-cyclodextrin. Pharm. Acta Helv. 74: 365-370.
    • (2000) Pharm. Acta Helv. , vol.74 , pp. 365-370
    • Özkan, Y.1    Atay, T.2    Dikmen, N.3    Işimer, A.4    Aboul-Enein, H.Y.5
  • 14
    • 0036195131 scopus 로고    scopus 로고
    • Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethyl cellulose complexes
    • Aggarwal, S., Singh, P.N., Mishra, B. 2002. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethyl cellulose complexes. Pharmazie. 57: 191-3.
    • (2002) Pharmazie , vol.57 , pp. 191-193
    • Aggarwal, S.1    Singh, P.N.2    Mishra, B.3
  • 17
    • 0020580178 scopus 로고
    • Inclusion complex formations of the anti-inflammatory drug flurbiprofen with cyclodextrins in aqueous solution and in solid state
    • Otagiri, M., Imai, T., Hirayama, F., Uekama, K., Yamasaki, M. 1983. Inclusion complex formations of the anti-inflammatory drug flurbiprofen with cyclodextrins in aqueous solution and in solid state. Acta Pharm. Suec. 20: 11-20.
    • (1983) Acta Pharm. Suec. , vol.20 , pp. 11-20
    • Otagiri, M.1    Imai, T.2    Hirayama, F.3    Uekama, K.4    Yamasaki, M.5
  • 18
    • 0029923106 scopus 로고    scopus 로고
    • A study on the differentiation between amorphous piroxicam: β-cyclodextrin complex and a mixture of the two amorphous components
    • Redenti, E., Peveri, T., Zanol, M., Ventura, P., Gnappi, G., Montenero, A. 1996. A study on the differentiation between amorphous piroxicam: β-cyclodextrin complex and a mixture of the two amorphous components. Int. J. Pharm. 129: 289-294.
    • (1996) Int. J. Pharm. , vol.129 , pp. 289-294
    • Redenti, E.1    Peveri, T.2    Zanol, M.3    Ventura, P.4    Gnappi, G.5    Montenero, A.6
  • 19
    • 0030919347 scopus 로고    scopus 로고
    • Solid state examination of a gliclazide: Beta-cyclodextrin complex
    • Winters, C.S., York, P., Timmins, P. 1997. Solid state examination of a gliclazide: beta-cyclodextrin complex. Eur. J. Pharm. Sci. 5: 209-214.
    • (1997) Eur. J. Pharm. Sci. , vol.5 , pp. 209-214
    • Winters, C.S.1    York, P.2    Timmins, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.